Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
ASX Announcements
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
8-Nov-2018
AGM presentations
5-Nov-2018
Kazia November Newsletter
30-Oct-2018
Kazia presents to AusBiotech Invest
29-Oct-2018
GDC-0084 update
26-Oct-2018
Becoming a substantial holder
24-Oct-2018
Section 708 notice
24-Oct-2018
Appendix 3B and Listing Rules disclosures
23-Oct-2018
Kazia Share Purchase Plan
22-Oct-2018
Kazia breast mets collaboration with Dana-Farber
18-Oct-2018
Reinstatement to Official Quotation
Previous
1
2
3
4
5
6
Next
